Healthcare


 Is Red Metal (ASX:RDM) Making Wise Decisions with Its Cash?

Is Red Metal (ASX:RDM) Making Wise Decisions with Its Cash?

March 20, 2025 01:31 PM AEDT| By Team Kalkine Media

Highlights,Red Metal shows a 14-month cash runway as of December 2024.,Cash burn reduced by 6% year over year.,Future cash raises may lead to shareholder dilution.,Shareholders of Red Metal (ASX:RDM) may notice the company's cash dynamics intriguing,...

 Rhythm Biosciences (ASX:RHY) Celebrates Milestone with Initial Commercial Sales of geneType Products

Rhythm Biosciences (ASX:RHY) Celebrates Milestone with Initial Commercial Sales of geneType Products

March 20, 2025 12:56 PM AEDT| By Team Kalkine Media

Highlights,First commercial sales recorded for,geneType,products.,Strategic growth targeted in enterprise and global markets.,Anticipation builds for upcoming,ColoSTAT,® revenue streams.,Rhythm Biosciences Ltd (ASX:RHY) has achieved a significant mil...

 Market Cautious on Doctor Care Anywhere Group (ASX:DOC) Despite Low Price-to-Sales Ratio

Market Cautious on Doctor Care Anywhere Group (ASX:DOC) Despite Low Price-to-Sales Ratio

March 20, 2025 12:52 PM AEDT| By Team Kalkine Media

Highlights,Doctor Care Anywhere Group sports a notably low P/S ratio.,Recent revenue trends fall short compared to industry growth.,Future revenue projections,remain,conservative against the industry.,Doctor Care Anywhere Group PLC (ASX:DOC) presents...

 Optimism in the Australian Healthcare Sector: Analysts Highlight CSL and ResMed

Optimism in the Australian Healthcare Sector: Analysts Highlight CSL and ResMed

March 20, 2025 11:43 AM AEDT| By Team Kalkine Media

Highlights,Positive outlook for CSL (CSL) and ResMed (RMD).,Balanced prospects for other healthcare stocks.,Caution,advised,for Ramsay Health Care and Cochlear.,The Australian healthcare sector is receiving a fresh wave of attention from analysts, wi...

 We Don't Have Major Concerns Regarding LTR Pharma's (LTP) Cash Burn Rate

We Don't Have Major Concerns Regarding LTR Pharma's (LTP) Cash Burn Rate

March 19, 2025 03:34 PM AEDT| By Team Kalkine Media

Highlights:,LTR Pharma maintains a strong cash position with no outstanding debt.,Recent cash burn increase attributed to operational expansion.,Future funding options include capital raising through share issuance.,The pharmaceutical sector continue...

 Imricor Medical Systems (ASX:IMR) Trading Halted Ahead of Capital Raising Announcement

Imricor Medical Systems (ASX:IMR) Trading Halted Ahead of Capital Raising Announcement

March 19, 2025 11:40 AM AEDT| By Team Kalkine Media

Highlights,Imricor,(IMR) shares suspended ahead of capital raising announcement.,Trading halt in effect until company provides details.,Imricor,plans significant financial move for future growth.,Imricor Medical Systems Ltd (ASX:IMR) has seen its sha...

 Emvision's Remote Stroke Detection Breakthrough and Biotech Sector Developments

Emvision's Remote Stroke Detection Breakthrough and Biotech Sector Developments

March 19, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Emvision Medical Devices (EMV) initiates trial for innovative remote stroke detection technology.,Despite challenging market conditions, several biotechs, including Imricor (IMR), successfully raise equity.,Imugene (IMU) secures FDA fast t...

 Syntara (ASX:SNT) shareholders have experienced remarkable returns, over the past year.

Syntara (ASX:SNT) shareholders have experienced remarkable returns, over the past year.

March 19, 2025 09:33 AM AEDT| By Team Kalkine Media

Highlights,SNT shares soared by an impressive 305% over the past year.,Recent financial results indicate significant revenue growth.,Long-term shareholders experienced a challenging three years.,While some investors are content with the steady approa...

 Pro Medicus Limited (ASX:PME) have recently been purchasing more shares.

Pro Medicus Limited (ASX:PME) have recently been purchasing more shares.

March 19, 2025 09:32 AM AEDT| By Team Kalkine Media

Highlights,Insiders hold 49% of ASX:PME shares, indicating significant vested interests.,Top 4 shareholders control 51% of the company, influencing key decisions.,Recent insider acquisitions suggest confidence in the company's growth.,To grasp who tr...

 Orthocell (ASX:OCC) Expands Global Footprint with Singapore Approval for Striate+

Orthocell (ASX:OCC) Expands Global Footprint with Singapore Approval for Striate+

March 18, 2025 05:08 PM AEDT| By Team Kalkine Media

Highlights,Singapore’s Health Sciences Authority grants approval for Striate+,Global sales growth continues with strong adoption rates,Expansion efforts underway with entry into new international markets,Orthocell (ASX:OCC) has secured regulatory app...

 CLEO Diagnostics initiates the transfer of intellectual property for ovarian cancer blood tests to manufacturers in the US.

CLEO Diagnostics initiates the transfer of intellectual property for ovarian cancer blood tests to manufacturers in the US.

March 18, 2025 03:31 PM AEDT| By Team Kalkine Media

Highlights:,CLEO Diagnostics progresses with technology transfer for its ovarian cancer blood test.,Collaboration with R&D Systems Inc supports antibody development for commercial prototypes.,Negotiations continue for selecting FDA-registered manufac...

 Would Next Science (NXS) Benefit from Reducing Its Debt?

Would Next Science (NXS) Benefit from Reducing Its Debt?

March 18, 2025 03:30 PM AEDT| By Team Kalkine Media

Highlights:,Next Science reports a low net debt position with liquid assets nearly balancing liabilities.,The company’s revenue has grown, though operating losses remain a key factor in financial assessments.,A focus on balance sheet improvement cont...

 Invex Therapeutics (ASX:IXC) - A Glimpse of Change

Invex Therapeutics (ASX:IXC) - A Glimpse of Change

March 18, 2025 03:30 PM AEDT| By Team Kalkine Media

Highlights,Invex Therapeutics shares increased by 12% in a week,A significant decrease of 88% over three years,Total Shareholder Return (TSR) outperforms share price drop,Invex Therapeutics Ltd (,ASX:IXC,) has witnessed a 12% rise in its share price...

 Chimeric Therapeutics (ASX:CHM) Launches $3.2M Entitlement Offer to Advance Cancer Trials

Chimeric Therapeutics (ASX:CHM) Launches $3.2M Entitlement Offer to Advance Cancer Trials

March 18, 2025 02:01 PM AEDT| By Team Kalkine Media

Highlights,Chimeric Therapeutics (CHM) announces a $3.2 million entitlement offer.,Funds to support ongoing clinical trials in neuroendocrine, colorectal, and blood cancers.,Eligible shareholders offered new shares at a 16.7% discount with,additional...

 Major Developments in ASX Health and Biotech Firms

Major Developments in ASX Health and Biotech Firms

March 18, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Nanosonics receives FDA clearance for Coris, aimed at improving infection control in hospitals.,Imricor secures substantial funding for accelerating its cardiac device, aiming at revolutionizing heart procedures.,PolyNovo tackles managemen...

 Medical Developments International (ASX:MVP) Sees Sharp Drop – What’s Behind It?

Medical Developments International (ASX:MVP) Sees Sharp Drop – What’s Behind It?

March 17, 2025 06:56 PM AEDT| By Team Kalkine Media

Highlights,Medical Developments International (MVP) has declined by 27% in the last month.,The stock's price-to-sales ratio is significantly lower than industry peers.,Revenue growth remains steady, but investor confidence seems uncertain.,Medical De...

 Global Health (ASX:GLH) Expands Digital Healthcare with $1 Million Youturn Partnership

Global Health (ASX:GLH) Expands Digital Healthcare with $1 Million Youturn Partnership

March 17, 2025 05:12 PM AEDT| By Team Kalkine Media

Highlights,Global Health (GLH) secures a $1 million contract with Youturn for digital health solutions.,The partnership aims to streamline operations across 12 healthcare organisations.,The deal includes innovative platforms to enhance service effici...

 Is Ansell Limited (ASX:ANN) Facing Market Pressure Due to Financial Performance?

Is Ansell Limited (ASX:ANN) Facing Market Pressure Due to Financial Performance?

March 17, 2025 02:01 PM AEDT| By Team Kalkine Media

Highlights,Ansell Limited (ANN) has seen a 7.2% decline in stock value over the past month.,The company's return on equity (ROE) stands at 5.9%, below the industry average of 9.9%.,Analysts expect future earnings growth, with ROE predicted to rise to...

 Ebos Group Dismisses Speculation on Real Pet Food Company Acquisition

Ebos Group Dismisses Speculation on Real Pet Food Company Acquisition

March 17, 2025 12:55 PM AEDT| By Team Kalkine Media

Highlights,Ebos,Group (,ASX:EBO,) refutes reports of pursuing Real Pet Food Company.,Company,maintains,its focus on strategic, small-to-medium acquisitions.,Official statement clarifies that the reported deal is inaccurate.,Ebos Group (ASX:EBO), a le...

 EMVision prepares for crucial stroke scanner trial this year

EMVision prepares for crucial stroke scanner trial this year

March 17, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights:,EMVision progresses from development to commercialization with portable brain scanners for stroke diagnosis.,A pivotal clinical trial supporting FDA approval of the emu bedside device is set to begin.,Collaboration with Keysight Technolog...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.